Abstract
Two of 33 prostatic tumour xenografts were established and passaged. Testosterone supplementation did not improve tumour take rates. The histological grade of the parent tumour was the principal factor affecting xenograft survival. Preliminary studies on established tumour xenografts suggest that their value lies in the study of tumour biology, and that they have no direct therapeutic application at present.
References
1.
Davies A.J.S.
,
Carter R.L.
,
Leuchars E.
,
Wallis V.
, &
Koller P.C.
(1969 ) Immunology 16 , 57 –69
2.
Davies A.J.S.
,
Leuchars E.
,
Wallis V.
, &
Koller P.C.
(1966 ) Transplantation 4 , 438 –451
3.
Greene H.S.N.
(1952 ) Cancer 5 , 24 –44
4.
Huggins C.H.
, &
Hodges C.V.
(1941 ) Cancer Research 1 , 293 –297
5.
Mickey D.D.
,
Stone K.R.
,
Wunderli H.
,
Mickey G.H.
,
Vollmer R.T.
, &
Paulson D.F.
(1977 ) Cancer Research 37 , 4049 –4053
6.
Okada K.
,
Schroeder F.H.
,
Jellinghaus W.
,
Wullstein H.K.
, &
Heinemeyer H.M.
(1976 ) Investigative Urology 13 , 395 –403
7.
Povlsen C.O.
, &
Rygaard J.
(1971 ) Acta Pathologia Microbiologia Scandinavica 79 , 159 –169
8.
Riverson A.
, &
Silverman J.
(1979 ) Investigative Urology 16 , 468 –472
9.
Sandberg A.A.
(1975 ) Vitamins and Hormones 33 , 167 –172
10.
Sandberg A.A.
, &
Gaunt R.
(1976 ) Seminars in Oncology 3 , 177 –187
11.
Sato G.
,
Desmond W.
, &
Kelly J.
(1975 ) Cancer Chemotherapy Reports 59 , 47 –49
12.
Williams G.
,
Ghanadian R.
,
Papadopoulos A.S.
, &
Castro J.E.
(1978 ) British Journal of Cancer 37 , 123 –125